# Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

> **NCT00209638** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hokkaido Gastrointestinal Cancer Study Group** · enrollment: 24 (—)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** irinotecan
- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT00209638
- **Lead sponsor:** Hokkaido Gastrointestinal Cancer Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 24 (—)
- **Last updated:** 2006-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209638, "Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT00209638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*